Moreover, in the mouse model of MASH, we found that ALI could decrease the level of F4/80 positive cells in the liver expressing CD86 while increasing the level of those expressing CD206 (Fig. 8L–N). The gene discussed is CD86; the disease is metabolic dysfunction-associated steatohepatitis.